Jeffrey G. Black's Net Worth
$6.37 Million
Who is Jeffrey G. Black?
Jeffrey G. Black has an estimated net worth of $6.37 Million. This is based on reported shares across multiple companies, which include Alphatec Holdings, Inc., Apollo Endosurgery, Inc., STANDARD BIOTOOLS INC., VERENIUM CORP, and EXAGEN INC..
SEC CIK
Jeffrey G. Black's CIK is 0001449439
Past Insider Trading and Trends
2009 was Jeffrey G. Black's most active year for acquiring shares with 10 total transactions. Jeffrey G. Black's most active month to acquire stocks was the month of July. 2013 was Jeffrey G. Black's most active year for disposing of shares, totalling 8 transactions. Jeffrey G. Black's most active month to dispose stocks was the month of September. 2021 saw Jeffrey G. Black paying a total of $1,522,250.00 for 375,000 shares, this is the most they've acquired in one year. In 2021 Jeffrey G. Black cashed out on 32,000 shares for a total of $523,830.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Alphatec Holdings, Inc. (ATEC) Snapshot price: $6.26
EVP & CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.12% | -7.00K |
$16.69 | -$116,830.00 | 620.77K |
Scheduled
|
Mar 9
| ||
Form 4
| -3.83% | -25.00K |
$16.28 | -$407,000.00 | 627.77K |
Scheduled
|
Feb 16
| ||
Form 4
| -0.76% | -5.00K |
$6.42 | -$32,100.00 | 652.77K |
Aug 11
| |||
Form 4
| -1.34% | -8.93K |
$5.03 | -$44,912.87 | 657.77K |
Scheduled
|
Aug 4
| ||
Form 4
| -3.44% | -23.77K |
$4.06 | -$96,522.44 | 666.7K |
May 14
| |||
Form 4
| +35.04% | 179.18K |
—
|
—
| 690.47K |
Apr 22
| |||
Form 4
| +1.19% | 6K |
$3.93 | $23,564.28 | 511.3K |
Apr 6
| |||
Form 4
| -1.28% | -6.56K |
$5.08 | -$33,307.22 | 505.3K |
Scheduled
|
Mar 10
| ||
Form 4
| -1.71% | -8.93K |
$4.75 | -$42,368.10 | 511.86K |
Scheduled
|
Aug 2
| ||
Form 4
| +194.16% | 343.75K |
—
|
—
| 520.79K |
May 13
| |||
Form 4
| +136.05% | 102.04K |
—
|
—
| 177.04K |
Jul 30
| |||
Form 4
| +46.69% | 15.87K |
—
|
—
| 49.87K |
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 8
| |||
Form 4
| +17.24% | 5K |
$1.80 | $9,000.00 | 34K |
Aug 17
| |||
Form 4
| +5.33% | 4K |
$1.75 | $7,000.00 | 79K |
Aug 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 26
| |||
Form 4
|
∞
| 25K |
—
|
—
| 25K |
Jul 14
| |||
Form 4
|
∞
| 75K |
—
|
—
| 75K |
Mar 29 - Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Apollo Endosurgery, Inc. No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -335.33K |
—
|
—
|
0
|
Apr 4
| |||
Form 4
| -4.33% | -15.06K |
$6.46 | -$97,287.60 | 332.65K |
Nov 4
| |||
Form 4
| -1.75% | -6.19K |
$6.46 | -$39,987.40 | 347.71K |
Aug 5
| |||
Form 4
| +33.55% | 88.9K |
—
|
—
| 353.9K |
Jun 14
| |||
Form 4
| +17.78% | 40K |
$5.73 | $229,100.00 | 265K |
Feb 25 - Mar 1
| |||
Form 4
|
∞
| 225K |
$8.75 | $218,750.00 | 225K |
Aug 9 - Aug 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
STANDARD BIOTOOLS INC. (LAB) Snapshot price: $1.94
SVP & Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.56% | -6.69K |
$1.91 | -$12,777.90 | 421.61K |
Aug 20
| |||
Form 4
| +2.02% | 8.46K |
$1.55 | -$7,277.25 | 428.3K |
Aug 15
| |||
Form 4
| +250.34% | 300K |
—
|
—
| 419.84K |
May 20
| |||
Form 4
| +39.37% | 33.85K |
$2.54 | -$47,698.66 | 119.84K |
May 15
| |||
Form 4
|
∞
| 85.98K |
$2.25 | $193,578.42 | 85.98K |
May 18 - May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
VERENIUM CORP No price found
Sr. Vice President & CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -6.13K |
$4.00 | -$24,500.00 |
0
|
Oct 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 2
| |||
Form 4
| +44.12% | 1.88K |
$1.99 | $3,751.75 | 6.13K |
Aug 15 - Aug 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 7
| |||
Form 4
|
∞
| 4.25K |
$2.78 | $11,827.50 | 4.25K |
Aug 16 - Aug 17
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Nov 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 12
| |||
Form 4
| -100.00% | -1.67K |
$0.63 | -$1,050.21 |
0
|
Scheduled
|
Dec 20
| ||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
EXAGEN INC. (XGN) Snapshot price: $3.49
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +827.39% | 225K |
—
|
—
| 252.19K |
Sep 1
| |||
| No matching records found | |||||||||